Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
50,554,743
-
Shares change
-
-2,145,611
-
Total reported value, excl. options
-
$560,557,135
-
Value change
-
-$37,822,320
-
Put/Call ratio
-
2.22%
-
Number of buys
-
74
-
Number of sells
-
-82
-
Price
-
$11.09
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q2 2015
202 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q2 2015.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,554,743 shares
of 294,683,714 outstanding shares and own 17.16% of the company stock.
Largest 10 shareholders include FMR LLC (4,269,815 shares), STATE STREET CORP (3,400,985 shares), BAKER BROS. ADVISORS LP (3,230,932 shares), WASATCH ADVISORS INC (3,091,386 shares), BlackRock Fund Advisors (2,561,830 shares), VANGUARD GROUP INC (2,331,734 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1,901,604 shares), Bank of New York Mellon Corp (1,879,926 shares), BlackRock Institutional Trust Company, N.A. (1,825,637 shares), and JENNISON ASSOCIATES LLC (1,731,499 shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.